Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.

Genentech Offers 10 Years of Refunds on High-Selling Drug, Multi-Year on Another; Merck to Give Single-Quarter Refunds

March 7, 2024 Rich Daly, Editor in Chief Views

Drugmaker Genentech announced multi-year refunds to 340B providers on past purchases of two separate high-selling drugs, while Merck offered a [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!